Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) – protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)

Feasibility, safety and effectiveness of prednisolone and vitamin B1, B6, and B12 in patients with post-COVID-19-syndrome (PreVitaCOV) – protocol of a randomised, double-blind, placebo-controlled multicentre trial in primary care (phase IIIb)

Abstract Background After infection with SARS-CoV-2 a relevant proportion of patients complains about persisting symptoms, a condition termed Post-COVID-19-syndrome (PC19S). So far, possible treatments are under investigation. Among others, neurotropic vitamins and anti-inflammatory substances are p...

Full description

Bibliographic Details
Main Authors: Caroline Tengelmann, Stefanie Joos, Yvonne Kaußner, Uwe Malzahn, Laura Lunden, Andreas Klug, Karl Georg Häusler, Catharina Escales, Walter Maetzler, Klemens Hügen, Oliver Zolk, Peter U. Heuschmann, Christian Förster, Hanna Kaduszkiewicz, Ildikó Gágyor
Format: Article
Language:English
Published: BMC 2024-01-01
Series:BMC Infectious Diseases
Subjects:
Post-COVID-19-Syndrome
Prednisolone
Vitamin B
Primary care
Randomised controlled trial
Online Access:https://doi.org/10.1186/s12879-023-08925-2

Internet

https://doi.org/10.1186/s12879-023-08925-2

Similar Items